Career history of Stephen Franklin
Former positions of Stephen Franklin
| Companies | Position | Start | End |
|---|---|---|---|
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Director/Board Member | 2007-12-31 | 2020-04-29 |
| Founder | 2007-12-31 | 2020-04-29 | |
| THERACRYF PLC | Director/Board Member | 2014-10-01 | 2020-04-29 |
| Chief Executive Officer | 2014-10-01 | 2020-04-29 | |
| Founder | 2006-12-31 | 2020-04-29 | |
| Investor Relations Contact | - | - | |
| PROVEXIS PLC | Chief Executive Officer | 2002-08-31 | 2007-06-30 |
| Founder | 2002-08-31 | 2007-06-30 | |
| ANGLE PLC | Corporate Officer/Principal | 1998-03-31 | 2002-08-31 |
| Manchester Biotech Ltd. | Corporate Officer/Principal | - | - |
Training of Stephen Franklin
| The University of Nottingham | Masters Business Admin |
| York University | Undergraduate Degree |
Statistics
International
| United Kingdom | 7 |
| Canada | 2 |
Operational
| Founder | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Services | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PROVEXIS PLC | Health Technology |
| ANGLE PLC | Distribution Services |
| THERACRYF PLC | Health Services |
| Private companies | 2 |
|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
| Manchester Biotech Ltd. |
- Stock Market
- Insiders
- Stephen Franklin
- Experience
